Syncfusion® Earns Global Recognition for Developer-First Innovation and Impact TELA Bio Announces Fourth Quarter and Full Year 2020 Financial Results
MALVERN, Pa., March 24, 2021 (GLOBE NEWSWIRE) — TELA Bio, Inc. (“TELA”), a commercial-stage medical…
Galapagos appoints Bart Filius as President and Chief Operating Officer
Mechelen, Belgium; 24 March 2021; 21.01 CET; Galapagos (Euronext & Nasdag; GLPG) announced today that…
Tauriga Sciences Inc. Expands its Pet Treats Product Offerings to 3 SKUs (Branded as: Tauri-Pet)
03_24 PR Image The 3 Distinct Tauri-Pet™ SKUs Commercial Launch of Tauri-Pet™ Product Line is…
Guerbet: 2020 annual results
2020 annual results Revenue in line with forecasts despite the health crisis: -12.8% at current…
Alliance for Regenerative Medicine Supports the Council Position on EU Joint Clinical Assessments
Alliance for Regenerative Medicine Supports the Council Position on EU Joint Clinical Assessments European Patients…
Fulcrum Therapeutics Appoints Judith A. Dunn, Ph.D. as President of Research and Development
CAMBRIDGE, Mass., March 24, 2021 (GLOBE NEWSWIRE) — Fulcrum Therapeutics, Inc. (Nasdaq: FULC), a clinical-stage biopharmaceutical…
HUTCHMED Enters Agreement to Divest Non-Core OTC Joint Venture for US$169Â Million
Allows focus on China and global clinical development and market launches of key Oncology/Immunology assets HONG…
AXIM® Biotechnologies’ Manufacturing Partner Empowered Diagnostics Files Emergency Use Authorization With FDA for Use of Its Rapid COVID-19 Neutralizing Antibody Test in Whole Blood at Point-of-Care Locations
SAN DIEGO, March 24, 2021 (GLOBE NEWSWIRE) — AXIM® Biotechnologies, Inc. (OTCQB: AXIM) (“AXIM® Biotech,”…
Revive Therapeutics Provides Update on FDA Phase 3 Clinical Trial for Bucillamine in COVID-19
TORONTO, March 24, 2021 (GLOBE NEWSWIRE) — Revive Therapeutics Ltd. (“Revive” or the “Company”) (CSE:…
ORYZON Publishes Vafidemstat First-in-Human Clinical Trial Manuscript in CNS Drugs Journal
Vafidemstat displayed good safety and tolerability in healthy young and elderly volunteers Paper confirms vafidemstat…
Arch Biopartners Enters Exclusive License Agreement with the University of Cincinnati for AB569 Topical Wound Treatment
TORONTO, March 24, 2021 (GLOBE NEWSWIRE) — Arch Biopartners Inc. (“Arch” or the “Company”) (TSX…
Praxis Precision Medicines to Present at Stifel’s 3rd Annual CNS Day
CAMBRIDGE, Mass., March 24, 2021 (GLOBE NEWSWIRE) — Praxis Precision Medicines, Inc. (NASDAQ: PRAX), a…
I-Mab to Host 2021 R&D Day
Mandarin session on April 7, 2021 and English session on April 26, 2021 for investors…
CytomX Therapeutics to Host Virtual Investor Event on April 7, 2021
SOUTH SAN FRANCISCO, Calif., March 24, 2021 (GLOBE NEWSWIRE) — CytomX Therapeutics, Inc. (Nasdaq: CTMX), a…
Beyond Air® to Present Abstracts at the American Thoracic Society Virtual Sessions in May 2021
GARDEN CITY, N.Y., March 24, 2021 (GLOBE NEWSWIRE) — Beyond Air, Inc. (NASDAQ: XAIR), a…
REN001 Granted Fast Track Designation by FDA for Patients with Primary Mitochondrial Myopathies
SAN DIEGO, March 24, 2021 (GLOBE NEWSWIRE) — Reneo Pharmaceuticals, Inc., a clinical stage pharmaceutical…
Radius Health Provides Update on Abaloparatide
Regulatory success achieved in Japan by partner Teijin Pharma Limited Ostabaro® approved for treatment of…
Auris Medical to Report Second Half and Full Year 2020 Financial Results and Provide Business Update on Wednesday, March 31, 2021
Hamilton, Bermuda, March 24, 2021 – Auris Medical Holding Ltd. (NASDAQ: EARS), a clinical-stage company…
Theratechnologies Announces First Patient Dosed in Phase 1 Clinical Trial of TH1902 for Sortilin Positive Solid Tumors
MONTREAL, March 24, 2021 (GLOBE NEWSWIRE) — Theratechnologies Inc. (Theratechnologies) (TSX: TH) (NASDAQ: THTX), a…
Abcam Wins Industry Awards from CiteAb
CAMBRIDGE, United Kingdom, March 24, 2021 (GLOBE NEWSWIRE) — Today Abcam (AIM:ABC; NASDAQ:ABCM), a global…